OptiBiotix ("OPTI") has had a strong start to 2020, with partners Agropur (US), Holland & Barrett (UK) and most recently Alfasigma (Italy) launching new products containing the company's microbiome-modulating functional ingredients. As an increasing number of products move to market, we remain positive as to the commercial potential of OPTI's functional ingredients as consumer awareness grows. The recent launches indicate growing momentum into 2020, when we expect existing agreements to s
27 Jan 2020
Product launches indicate growing momentum for year ahead
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Product launches indicate growing momentum for year ahead
OptiBiotix Health PLC (OPTI:LON) | 21.0 0 0.0% | Mkt Cap: 19.2m
- Published:
27 Jan 2020 -
Author:
KIERON BANERJEE -
Pages:
5
OptiBiotix ("OPTI") has had a strong start to 2020, with partners Agropur (US), Holland & Barrett (UK) and most recently Alfasigma (Italy) launching new products containing the company's microbiome-modulating functional ingredients. As an increasing number of products move to market, we remain positive as to the commercial potential of OPTI's functional ingredients as consumer awareness grows. The recent launches indicate growing momentum into 2020, when we expect existing agreements to s